<html><body><h2>Case: 2410478</h2><h3> CDS Time: 1958-11-08</h3>
<patient name=2410478>
58.0 year old Unknown_Race Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">58</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">9</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">130</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">68</td><td width="200">1957-8-6</td></tr>
<tr><td width="200">Chloride</td><td width="200">87.0</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">25</td><td width="200">1957-8-6</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">66</td><td width="200">1958-7-12</td></tr>
<tr><td width="200">BNP</td><td width="200">1377.0</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Weight</td><td width="200">190</td><td width="200">1958-7-12</td></tr>
<tr><td width="200">HbA1C</td><td width="200">8</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">86</td><td width="200">1957-8-6</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">107</td><td width="200">1957-8-6</td></tr>
<tr><td width="200">SGOT</td><td width="200">73</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">100</td><td width="200">1958-7-12</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">1</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Height</td><td width="200">68</td><td width="200">1958-7-12</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">107</td><td width="200">1957-8-6</td></tr>
<tr><td width="200">BUN</td><td width="200">39</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">HCT</td><td width="200">43</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">HGB</td><td width="200">15</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Sodium</td><td width="200">132</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Creatinine</td><td width="200">2.1</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">8</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Pulse</td><td width="200">86</td><td width="200">1958-7-12</td></tr>
<tr><td width="200">PLT</td><td width="200">333</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">WBC</td><td width="200">9</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">eGFR</td><td width="200">47</td><td width="200">1958-6-1</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1958-10-18</td></tr>
<tr><td width="200">SGPT</td><td width="200">49</td><td width="200">1958-6-28</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1958-8-27</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1958-10-18</td></tr>
<tr><td width="200">Race</td><td width="200">Unknown_Race</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">Osteoporosis</td><td width="200"></td><td width="200">1958-10-18</td></tr>
</table>
<p><b>Medications:</b> aspirin(81.0) propranolol(60.0) spironolactone(25.0) simvastatin(40.0) nitrate(60.0) furosemide(160.0) lovastatin(40.0) Insulin(60.0) valsartan(240.0) carvedilol(6.25) digoxin(0.125) eplerenone(12.5) hydralazine(75.0) hydrochlorothiazide(75.0) amiodarone(400.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Osteoporosis</td>
<td width="200">1958-10-18</td>
<td width="200"> Osteoporosis()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1958-08-27</td>
<td width="200"> Heart_Failure()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1958-10-18</td>
<td width="200"> DM-Type2()</td></tr>
<tr><td width="200">Creatinine > 1.5 and Male</td>
<td width="200"></td>
<td width="200"> Creatinine > 1.5 and Male[Creatinine(2.1/1958-6-28) && Sex(Male)]()</td></tr>
<tr><td width="200">Serum creatinine >=2</td>
<td width="200"></td>
<td width="200"> Serum creatinine >=2mg/dl[Creatinine(2.1/1958-6-28)]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA DM: Glycemic Control</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA DM: Glycemic Control: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(diabetes_mellitus)</i>]
<li>Creatinine > 1.5 and Male: [because <i> Creatinine > 1.5 and Male </i> evaluate to <b>true</b><i>(Creatinine(2.1/1958-6-28) && Sex(Male))</i>]
</ul>
<b>Scenario choice:</b> Insulin therapy only
<p>
<b>Goal:</b> HBA1C <= target(presence of target HBA1C)
<p><b>Reached goal?</b> failed(HbA1C(7.7/1958-6-28))
<p><b>Action Choices</b>
<ul>
<li><b>DM -  Insulin only</b><br>
<ul>
<li><b>Is patient high risk? If yes, refer <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])


<li><b>Metformin contraindicated, add Glipizide <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HbA1C > Target_HbA1c</i> evaluate to <b> true</b> because <i>HbA1C(7.7/1958-6-28)</i>)])
Add Glipizide
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>GLIPIZIDE(GLIPIZIDE)<ul><li>Relative indications:  DM-Type2(DM-Type2) <li>Sulfonylurea general info when prescribing(•	Efficacy ( HbA1c) a = 1.0 - 2.0 %
•	1st generation sulfonylureas are no longer commonly used.
•	No difference in long term efficacy or failure rate has been demonstrated among the sulfonylureas.
•	The preferred agents have shorter half-lives and inactive metabolites.
•	1st generation sulfonylureas are 100% renally eliminated. Chlorpropamide and tolazamide have active metabolites.
•	Glipizide, glyburide, and glimepiride are renally eliminated by 80 - 85%, 50%, and 60% respectively. All but glipizide have active metabolites.
•	Inexpensive)<li>preference: preferred</ul></ul></body></html>